We are a not for profit organisation with charitable status. Our funding comes from a number of sources.
We receive grant income from the Health Research Board, and the Irish Cancer Society. In 2024, grants represented 52% of our total income (2023 46%). Study Income, whereby funded studies are supported by industry and international collaborations was 32% of total income in 2024 (2023 37%). Donations represented 13% of income in 2024 (2023 13%), and philanthropic income for restricted disease types represented 3% of total income in 2024 (2023 4%).
From the €3 million invested by the Exchequer in 2016, Cancer Trials Ireland generated an additional €4.5 million in income from other sources, saving the Irish Health Service Executive (HSE) at least €6.5 million in cancer drugs-costs, generated almost €6 million in tax revenues, contributed €16.5 million to Ireland’s GDP and supported over 230 jobs, mostly high quality specialist positions.
This income is also vital to enable our Cancer Trials Research Units around the country to keep in place the expertise and facilities to meet the Health Protection Regulatory Authority’s (HPRA) regulatory requirements, compete for international trials and undertake non-commercial and collaborative trials that are not fully funded by pharmaceutical funding.
In addition to receiving grant income, over half of our income is earned by managing and monitoring cancer trials for other research groups like ourselves that are based outside Ireland.
We also receive donations from the public. If you would like to contribute to Cancer Trials Ireland and cancer research in Ireland please see our donate section.